Solid Biosciences Inc. develops therapies for neuromuscular and cardiac diseases in the United States. The company's lead product candidate is SGT-003, which is in phase 1/2 for the treatment of Duchenne muscular dystrophy. It develops SGT-...
Leadership
Ian F. Smith A.C.A., C.P.A.
Executive Chair
Alexander G. Cumbo
President, CEO & Director
Ilan GanotFounder
Co-founder, Strategic Advisor to the CEO & Director
David Tyronne Howton Jr., J.D.
COO & Secretary
Gabriel Brooks M.D.
Chief Medical Officer
Annie GanotFounder
Co-Founder & VP of Patient Advocacy
Kevin Tan C.F.A.
CFO & Treasurer
Paul Herzich
Chief Technology Officer
Nicole Anderson
Senior Director of Investor Relations & Corporate Communications
